Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.66M Buy
276,600
+2,900
+1% +$75.9K 0.01% 1080
2026
Q1
$7.69M Sell
273,700
-340,600
-55% -$9.07M 0.01% 900
2025
Q4
$15.3M Sell
614,300
-527,000
-46% -$13.3M 0.03% 519
2025
Q3
$29.1M Sell
1,141,300
-542,300
-32% -$13.4M 0.05% 304
2025
Q2
$40.8M Buy
1,683,600
+1,328,600
+374% +$31M 0.09% 160
2025
Q1
$9M Buy
355,000
+337,900
+1,976% +$8.84M 0.03% 510
2024
Q4
$454K Sell
17,100
-481,700
-97% -$13.1M ﹤0.01% 2308
2024
Q3
$14.4M Sell
498,800
-598,300
-55% -$17.5M 0.05% 276
2024
Q2
$30.7M Buy
1,097,100
+403,500
+58% +$11.1M 0.16% 89
2024
Q1
$19.2M Sell
693,600
-113,300
-14% -$3.14M 0.12% 142
2023
Q4
$23.2M Buy
806,900
+296,800
+58% +$8.97M 0.19% 90
2023
Q3
$16.9M Buy
510,100
+234,500
+85% +$8.29M 0.17% 90
2023
Q2
$10.1M Buy
275,600
+236,100
+598% +$9.19M 0.12% 172
2023
Q1
$1.61M Buy
+39,500
New +$1.71M 0.02% 902
2022
Q1
Sell
-5,900
Closed -$348K 2509
2021
Q4
$348K Sell
5,900
-141,100
-96% -$6.99M 0.01% 1738
2021
Q3
$6.32M Buy
+147,000
New +$6.51M 0.1% 197
2013
Q3
Sell
-685,100
Closed -$18.2M 923
2013
Q2
$18.2M Buy
+685,100
New +$18.9M 1.37% 12

Other funds holding PFE

Paul Tudor Jones's PFE Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Pfizer (PFE) in Q2 2026: 697,000 shares worth $16.8M. The stake represents 0.02% of the portfolio and ranks #570 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in PFE as recently as Q4 2025.

Paul Tudor Jones first reported a position in PFE in Q2 2013 and has held it in 39 quarters since. The position peaked at $39.6M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Paul Tudor Jones held 697,000 shares of Pfizer worth $16.8M as of Q2 2026.
  • Pfizer was a new Paul Tudor Jones position in Q2 2026.
  • Pfizer made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #570 holding.
  • Paul Tudor Jones first reported a position in Pfizer in Q2 2013 and has held it in 39 quarters since.
  • Paul Tudor Jones's Pfizer position peaked at $39.6M in Q1 2015.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.